New combo therapy aims to shrink lung tumors in advanced cancer patients
NCT ID NCT07111520
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study tests two experimental drugs, BNT326 and BNT327, together in people with advanced non-small cell lung cancer that has spread or come back. The goal is to find the best dose and see if the combination can shrink tumors. About 420 adults will take part, including those who have not had treatment before or whose cancer got worse after prior therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Oncology, ARENSIA Exploratory Medicine
RECRUITINGChisinau, 2025, Moldova
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.